BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32188907)

  • 1. Optimal Timing of Radiotherapy Following Gross Total or Subtotal Resection of Glioblastoma: A Real-World Assessment using the National Cancer Database.
    Buszek SM; Al Feghali KA; Elhalawani H; Chevli N; Allen PK; Chung C
    Sci Rep; 2020 Mar; 10(1):4926. PubMed ID: 32188907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Extent of Resection in Glioblastoma: Analysis from a Large Database.
    Trifiletti DM; Alonso C; Grover S; Fadul CE; Sheehan JP; Showalter TN
    World Neurosurg; 2017 Jul; 103():330-340. PubMed ID: 28427986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.
    Randolph DM; McTyre ER; Paulsson AK; Holmes JA; Hinson WH; Lesser GJ; Strowd R; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
    Clin Neurol Neurosurg; 2016 Dec; 151():73-78. PubMed ID: 27816029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of resection and radiotherapy in GBM: A 1973 to 2007 surveillance, epidemiology and end results analysis of 21,783 patients.
    Zinn PO; Colen RR; Kasper EM; Burkhardt JK
    Int J Oncol; 2013 Mar; 42(3):929-34. PubMed ID: 23338774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
    Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD; Olson JJ; Hasan S; Blumenthal DT; Curran WJ; Eaton BR; Shu HG; Zhong J
    Cancer; 2020 Jul; 126(14):3255-3264. PubMed ID: 32342992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy.
    Kreth FW; Thon N; Simon M; Westphal M; Schackert G; Nikkhah G; Hentschel B; Reifenberger G; Pietsch T; Weller M; Tonn JC;
    Ann Oncol; 2013 Dec; 24(12):3117-23. PubMed ID: 24130262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
    Orton A; Frandsen J; Jensen R; Shrieve DC; Suneja G
    J Neurosurg; 2018 Jun; 128(6):1684-1689. PubMed ID: 28731397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes and Patterns of Care in Elderly Patients with Glioblastoma Multiforme.
    Nunna RS; Khalid SI; Patel S; Sethi A; Behbahani M; Mehta AI; Adogwa O; Byrne RW
    World Neurosurg; 2021 May; 149():e1026-e1037. PubMed ID: 33482415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.
    Bloch O; Han SJ; Cha S; Sun MZ; Aghi MK; McDermott MW; Berger MS; Parsa AT
    J Neurosurg; 2012 Dec; 117(6):1032-8. PubMed ID: 23039151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of management and outcomes of unifocal versus multifocal glioblastoma.
    Haque W; Thong Y; Verma V; Rostomily R; Brian Butler E; Teh BS
    J Clin Neurosci; 2020 Apr; 74():155-159. PubMed ID: 32089384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined-Modality Therapy With Radiation and Chemotherapy for Elderly Patients With Glioblastoma in the Temozolomide Era: A National Cancer Database Analysis.
    Rusthoven CG; Koshy M; Sher DJ; Ney DE; Gaspar LE; Jones BL; Karam SD; Amini A; Ormond DR; Youssef AS; Kavanagh BD
    JAMA Neurol; 2016 Jul; 73(7):821-8. PubMed ID: 27214765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A; Schmitz AL; Knoll A; Schneider M; Hlavac M; König R; Wirtz CR; Coburger J
    Clin Neurol Neurosurg; 2018 Apr; 167():6-10. PubMed ID: 29425743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
    Konar SK; Bir SC; Maiti TK; Nanda A
    J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
    Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
    J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The detrimental effect of biopsy preceding resection in surgically accessible glioblastoma: results from the national cancer database.
    Zhu P; Pichardo-Rojas PS; Dono A; Tandon N; Hadjipanayis CG; Berger MS; Esquenazi Y
    J Neurooncol; 2024 May; 168(1):77-89. PubMed ID: 38492191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
    McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
    J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Gross Total Resection in World Health Organization Grade II Astrocytomas: SEER-Based Survival Analysis.
    Schupper AJ; Hirshman BR; Carroll KT; Ali MA; Carter BS; Chen CC
    World Neurosurg; 2017 Jul; 103():741-747. PubMed ID: 28419878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma.
    Jackson WC; Tsien CI; Junck L; Leung D; Hervey-Jumper S; Orringer D; Heth J; Wahl DR; Spratt DE; Cao Y; Lawrence TS; Kim MM
    J Neurooncol; 2018 May; 138(1):155-162. PubMed ID: 29388034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for Glioblastoma in Light of Molecular Markers: Impact of Resection and MGMT Promoter Methylation in Newly Diagnosed IDH-1 Wild-Type Glioblastomas.
    Gessler F; Bernstock JD; Braczynski A; Lescher S; Baumgarten P; Harter PN; Mittelbronn M; Wu T; Seifert V; Senft C
    Neurosurgery; 2019 Jan; 84(1):190-197. PubMed ID: 29617848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoprogression in glioblastoma patients: the impact of extent of resection.
    Park HH; Roh TH; Kang SG; Kim EH; Hong CK; Kim SH; Ahn SS; Lee SK; Choi HJ; Cho J; Kim SH; Lee KS; Suh CO; Chang JH
    J Neurooncol; 2016 Feb; 126(3):559-66. PubMed ID: 26608521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.